glycopyrronium martindale 200 mikrog/ml injektioneste, liuos
ethypharm - glycopyrronium bromide - injektioneste, liuos - 200 mikrog/ml - glykopyrroniumbromidi
robinul 0.2 mg/ml injektioneste, liuos
viatris oy - glycopyrronium bromide - injektioneste, liuos - 0.2 mg/ml - glykopyrroniumbromidi
bevespi aerosphere
astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - keuhkosairaus, krooninen obstruktiivinen - formoteroli ja glykopyrroniumbromidi - bevespi aerosphere on merkitty huolto keuhkoputkia hoito lievittää oireita aikuisilla potilailla, joilla on krooninen keuhkoahtaumatauti (copd).
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - obstruktiivisten hengitystiesairauksien lääkkeet, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - keuhkosairaus, krooninen obstruktiivinen - obstruktiivisten hengitystiesairauksien lääkkeet, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - obstruktiivisten hengitystiesairauksien lääkkeet, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - keuhkosairaus, krooninen obstruktiivinen - obstruktiivisten hengitystiesairauksien lääkkeet, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
robinul-neostigmin 0.5 mg/ml + 2.5 mg/ml injektioneste, liuos
viatris oy - glycopyrronium bromide, neostigmine metilsulfate - injektioneste, liuos - 0.5 mg/ml + 2.5 mg/ml - neostigmiini
glycostigmin injektioneste, liuos
takeda oy - glycopyrronium bromide, neostigmine metilsulfate - injektioneste, liuos - neostigmiini
glykopyrroniumbromidi accord 200 mikrog/ml injektioneste, liuos
accord healthcare b.v. - glycopyrronium bromide - injektioneste, liuos - 200 mikrog/ml - glykopyrroniumbromidi